Dual effect of hypochlorite in the modification of high density lipoproteins

Biochemical and Biophysical Research Communications

Volumn 403, Issue 3-4, 2010, Pages 447-451

  Pirillo, Angela ^a   Uboldi, Patrizia ^a   Catapano, Alberico L ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS MULTIMEDICA   (Italy)

Author keywords

ABCA1; Adhesion molecules; Cholesterol efflux; HDL; Myeloperoxidase; Pre particles

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; ARACHIDONATE 15 LIPOXYGENASE; COPPER ION; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHLORITE; LIPID; MYELOPEROXIDASE;

AGAR GEL ELECTROPHORESIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; MACROPHAGE; PRIORITY JOURNAL; PROTEIN MODIFICATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CELL LINE; CHOLESTEROL; HYPOCHLOROUS ACID; INFLAMMATION; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL3; MACROPHAGES; MICE;

MUS;

EID: 78650178300     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.053     Document Type: Article

References (29)

1. Gotto A.M., Brinton E.A. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. J. Am. Colloid Cardiol. 2004, 43:717-724.
2. Kontush A., Chapman M.J. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 2006, 58:342-374.
3. Ansell B.J., Fonarow G.C., Fogelman A.M. The paradox of dysfunctional high-density lipoprotein. Curr. Opin. Lipidol. 2007, 18:427-434.
4. Bergt C., Pennathur S., Fu X., Byun J., O'Brien K., McDonald T.O., Singh P., Anantharamaiah G.M., Chait A., Brunzell J., Geary R.L., Oram J.F., Heinecke J.W. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proc. Natl. Acad. Sci. USA 2004, 101:13032-13037.
5. Suc I., Brunet S., Mitchell G., Rivard G.E., Levy E. Oxidative tyrosylation of high density lipoproteins impairs cholesterol efflux from mouse J774 macrophages: role of scavenger receptors, classes A and B. J. Cell Sci. 2003, 116:89-99.
6. Marsche G., Hammer A., Oskolkova O., Kozarsky K.F., Sattler W., Malle E. Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport. J. Biol. Chem. 2002, 277:32172-32179.
7. Zheng L., Nukuna B., Brennan M.L., Sun M., Goormastic M., Settle M., Schmitt D., Fu X., Thomson L., Fox P.L., Ischiropoulos H., Smith J.D., Kinter M., Hazen S.L. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J. Clin. Invest. 2004, 114:529-541.
8. Shao B., Oda M.N., Oram J.F., Heinecke J.W. Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein. Curr. Opin. Cardiol. 2006, 21:322-328.
9. Undurti A., Huang Y., Lupica J.A., Smith J.D., DiDonato J.A., Hazen S.L. Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. J. Biol. Chem. 2009, 284:30825-30835.
10. Hazen S.L., Heinecke J.W. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. J. Clin. Invest. 1997, 99:2075-2081.
11. Shao B., Bergt C., Fu X., Green P., Voss J.C., Oda M.N., Oram J.F., Heinecke J.W. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. J. Biol. Chem. 2005, 280:5983-5993.
12. Pirillo A., Uboldi P., Kuhn H., Catapano A.L. 15-Lipoxygenase-mediated modification of high-density lipoproteins impairs SR-BI- and ABCA1-dependent cholesterol efflux from macrophages. Biochim. Biophys. Acta 2006, 1761:292-300.
13. Pirillo A., Uboldi P., Pappalardo G., Kuhn H., Catapano A.L. Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux. Cardiovasc. Res. 2007, 75:566-574.
14. Ades E.W., Candal F.J., Swerlick R.A., George V.G., Summers S., Bosse D.C., Lawley T.J. HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J. Invest. Dermatol. 1992, 99:683-690.
15. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1955, 34:1345-1353.
16. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
17. Basu S.K., Goldstein J.L., Anderson G.W., Brown M.S. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc. Natl. Acad. Sci. USA 1976, 73:3178-3182.
18. Norata G.D., Marchesi P., Pirillo A., Uboldi P., Chiesa G., Maina V., Garlanda C., Mantovani A., Catapano A.L. Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 2008, 28:925-931.
19. Pirillo A., Uboldi P., Bolego C., Kuhn H., Catapano A.L. The 15-lipoxygenase-modified high density lipoproteins 3 fail to inhibit the TNF-alpha-induced inflammatory response in human endothelial cells. J. Immunol. 2008, 181:2821-2830.
20. Pirillo A., Uboldi P., Pappalardo G., Kuhn H., Catapano A.L. Modification of HDL(3) by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux. Cardiovasc. Res. 2007.
21. Heinecke J.W. The role of myeloperoxidase in HDL oxidation and atherogenesis. Curr. Atheroscler. Rep. 2007, 9:249-251.
22. Malle E., Marsche G., Panzenboeck U., Sattler W. Myeloperoxidase-mediated oxidation of high-density lipoproteins: fingerprints of newly recognized potential proatherogenic lipoproteins. Arch. Biochem. Biophys. 2006, 445:245-255.
23. Nicholls S.J., Zheng L., Hazen S.L. Formation of dysfunctional high-density lipoprotein by myeloperoxidase. Trends Cardiovasc. Med. 2005, 15:212-219.
24. Shao B., Oda M.N., Bergt C., Fu X., Green P.S., Brot N., Oram J.F., Heinecke J.W. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. J. Biol. Chem. 2006, 281:9001-9004.
25. Vaisar T., Shao B., Green P.S., Oda M.N., Oram J.F., Heinecke J.W. Myeloperoxidase and inflammatory proteins: pathways for generating dysfunctional high-density lipoprotein in humans. Curr. Atheroscler. Rep. 2007, 9:417-424.
26. Pennathur S., Bergt C., Shao B., Byun J., Kassim S.Y., Singh P., Green P.S., McDonald T.O., Brunzell J., Chait A., Oram J.F., O'Brien K., Geary R.L., Heinecke J.W. Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J. Biol. Chem. 2004, 279:42977-42983.
27. McCall M.R., Carr A.C., Forte T.M., Frei B. Ldl modified by hypochlorous acid is a potent inhibitor of lecithin-cholesterol acyltransferase activity. Arterioscler. Thromb. Vasc. Biol. 2001, 21:1040-1045.
28. Mancini M.C., Kairdolf B.A., Smith A.M., Nie S. Oxidative quenching and degradation of polymer-encapsulated quantum dots: new insights into the long-term fate and toxicity of nanocrystals in vivo. J. Am. Chem. Soc. 2008, 130:10836-10837.
29. Wang N., Silver D.L., Thiele C., Tall A.R. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J. Biol. Chem. 2001, 276:23742-23747.